Dysmenorrhea Treatment Market Size, Share, Trend, Growth: By Type (Primary Dysmenorrhea and Secondary Dysmenorrhea), Type of Treatment (Pain Relievers, Hormonal Therapy and Surgery) End User (Hospitals & Clinics, Research Centers and others) and Region (the Americas, Europe, Asia-Pacific and Middle East & Africa) – Global Forecast till 2025
Dysmenorrhea Treatment Market – Highlights
Pain during menstruation is known as Dysmenorrhea Treatment Market. Increase in incidence of dysmenorrhea, which is attributed to changing lifestyle, addiction to smoking and alcohol, hormonal changes and physical and mental stress, favor the growth of this market. Additionally, lack of awareness regarding reproductive health and increase in first pregnancy age, favor the growth of this market.
Taste the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Dysmenorrhea Treatment Market Research Report –Global Forecast to 2023.”
Global Dysmenorrhea Treatment Market – Players
Key players in Dysmenorrhea Treatment Market Players are: Novartis AG (Switzerland), Merck, Inc. (U.S), Bayer Schering Pharma AG (Germany), Abbott Healthcare (U.S), Pfizer, Inc. (U.S). Other players include F. Hoffmann-La Roche Ltd (U.S), Sanofi (U.S), Taj Pharmaceuticals, Ltd (India).
Dysmenorrhea Treatment Market- Segmentation
Global Dysmenorrhea Treatment market has been segmented on the basis of Type which includes Primary Dysmenorrhea and Secondary Dysmenorrhea. Secondary Dysmenorrhea has sub-segments namely Endometriosis, Adenomyosis, Uterine myomas, Endometrial polyps, Cervical stenosis, Obstructive malformations of genital tract. On the basis of treatment the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), hormonal, and combined oral contraceptive. End users are hospitals and clinics, diagnostic centers, pharmaceutical companies and others.
Dysmenorrhea Treatment Market – Regional Analysis
Globally, Dysmenorrhea Treatment market is spread across four regions America, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market for dysmenorrhea. The factor contributing for the growth of this market is an increase in problems with reproductive healthy among women and changing lifestyle. Asia Pacific is expected to be the fastest growing market for dysmenorrhea treatment. India is expected to be the emerging and fastest growing region. The market shows steady growth in Middle East and Africa.
Get More Report for Pharmaceutical at https://www.marketresearchfuture.com/categories/pharmaceutical-market-report
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312